15 April 2026 : Clinical Research
Phospho-Histone H3 as a Tool for Improved Mitotic Counting and Risk Assessment in Gastrointestinal Stromal Tumors: A Study of 241 Cases
Xu Liu
ADE 1,2, Jiao Liu BC 3, Yahui Cui CF 4, Hanhan Lei CD 1,2, Yuchang Hu DG 1,2, Yufei Liu DG 1,2*
DOI: 10.12659/MSM.952182
Med Sci Monit 2026; 32:e952182
Figure 5 Intra-observer variability results of mitotic count on hematoxylin-eosin (MC-HE) compared with mitotic count on phospho-histone H3 (MC-PHH3). R=0.775 (A), R=0.708 (B), and R=0.899 (C).